Back to Top

Antiviral Research (AR)

Publisher :

Elsevier

  • Pharmacology
  • Toxicology
  • Pharmaceutics
  • +3

e-ISSN :

1872-9096

Issue Frequency :

Monthly

Impact Factor :

7.6

p-ISSN :

0166-3542

Est. Year :

1959

Mobile :

31204853767

Country :

Netherlands The

Language:

English

APC :

YES

Email :

nlinfo@sciencedirect.com

Journal Descriptions

A journal for research on the prevention and treatment of viral diseases An Official Publication of the International Society for Antiviral Research Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses: antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action. new or improved vaccines against viral infections of humans; assessments of drug and vaccine safety; evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures; identification and validation of new drug targets; laboratory animal models of viral diseases; pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.


Antiviral Research (AR) is :

International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Toxicology, Pharmaceutics, Microbiology, Virology, Immunology , Online or Print, Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 0166-3542, E-ISSN - 1872-9096, Established in - 1959, Impact Factor - 7.6

Not Provide Crossref DOI

Indexed in Scopus

Not indexed in WoS, DOAJ, PubMed, UGC CARE

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile